Full history for every metric is available with a Kvantra account
Key financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | €m | 150 | 166 | 201 | 319 | 394 | 468 | 497 | 561 |
| Operating profit | €m | 102 | 89 | ||||||
| Net profit | €m | -16 | -149 | 11 | 17 | 31 | 43 | 58 | 107 |
| EPS reported | € | 0.84 | 0.59 | ||||||
| Operating cashflow per share | € | 1.94 | 2.32 | ||||||
| Capex per share | € | 0.98 | 1.21 | ||||||
| FCF per share | € | 0.95 | 1.11 | ||||||
| Free cash flow | €m | 49 | 57 | ||||||
| Net debt | €m | 161 | 164 | ||||||
| Book value equity | €m | 446 | 451 | ||||||
| Book value per share | € | 8.75 | 8.85 | ||||||
| Number of shares | m | 50.94 | 50.93 | ||||||
| DPS (TTM paid) | € | 0.30 | 0.30 |
Financial summary
Financials in EUR| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E TTM | x | 57.68 | - | ||||||
| P/B LTM | x | 5.54 | 6.70 | ||||||
| P/S LTM | x | 5.27 | 6.08 | ||||||
| P/FCF LTM | x | 50.88 | 53.42 | ||||||
| EV/EBITDA LTM | x | 18.85 | 19.63 | ||||||
| EV/Sales LTM | x | 5.72 | 6.41 | ||||||
| Earnings Yield LTM | % | 1.73% | 1.91% | ||||||
| FCF Yield | % | 1.97% | 1.87% | ||||||
| Quality | |||||||||
| ROE | % | 9.58% | 12.85% | ||||||
| ROIC | % | 10.54% | 8.90% | ||||||
| Operating margin | % | 21.83% | 17.96% | ||||||
| Gross margin | % | 21.83% | 17.43% | ||||||
| FCF/Sales | % | 10.36% | 11.38% | ||||||
| Growth and momentum | |||||||||
| EPS Growth YoY | % | +40.00% | -50.83% | ||||||
| Sales Growth YoY | % | +18.80% | +15.07% | ||||||
| Net Income Growth YoY | % | +39.09% | +3.31% | ||||||
| FCF Growth | % | -49.58% | +18.12% | ||||||
| Operating Profit Growth | % | +32.90% | -6.93% | ||||||
| Dividend and capital structure | |||||||||
| Dividend Yield | % | 0.21% | 0.49% | ||||||
| Dividend Growth | % | +200.00% | +200.00% | ||||||
| Payout Ratio | % | 11.92% | 11.94% | ||||||
| FCF/Debt | x | 0.17 | 0.21 | ||||||
| Net Debt/EBITDA | x | 1.49 | 1.24 | ||||||
| EBIT/Net interest | x | 7.41 | 7.66 | ||||||
| Net debt/market cap | % | 6.54% | 5.44% | ||||||
| Net debt/Equity | x | 0.36 | 0.36 | ||||||
| Gross debt/equity | x | 0.63 | 0.60 | ||||||
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Based on consensus from external analysts. Not Kvantra's opinion.
Exosens specializes in the development, production, and global distribution of advanced electro-optical technologies. Its core expertise lies in amplification, detection, and imaging solutions, catering to markets across France, the rest of Europe, North America, Asia, Oceania, and Africa, as well as other international territories. The company's extensive product portfolio features image intensifier tubes; a diverse array of cameras covering ultraviolet, short-wave, long-wave, visible-near infrared, and mid-wave infrared spectra; and enhanced vision equipment. Exosens further provides ion, electron, scintillation, and single photon detection products; X-ray components, neutronic imaging systems, and image intensifiers tailored for scientific applications; alongside gamma and neutron detectors, and mineral insulated extensions. Additionally, it supplies power tubes, microwave devices, and airborne solutions for methane detection. Operating under prominent brands including Photonis, Xenics, Telops, and El-Mul, Exosens serves vital sectors such as defense and surveillance, industrial research and control, life science and environmental monitoring, and the nuclear industry. Established in 1937 and headquartered in Mérignac, France, Exosens functions as a subsidiary of HLD Europe S.C.A.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free